LOGROSCINO, Giancarlo
 Distribuzione geografica
Continente #
NA - Nord America 30.642
AS - Asia 12.468
EU - Europa 10.592
SA - Sud America 2.917
AF - Africa 773
OC - Oceania 171
Continente sconosciuto - Info sul continente non disponibili 22
Totale 57.585
Nazione #
US - Stati Uniti d'America 30.133
SG - Singapore 4.379
IT - Italia 2.881
CN - Cina 2.348
BR - Brasile 2.290
HK - Hong Kong 1.775
RU - Federazione Russa 1.628
DE - Germania 1.088
SE - Svezia 1.054
FR - Francia 822
GB - Regno Unito 797
FI - Finlandia 690
VN - Vietnam 687
UA - Ucraina 617
IN - India 600
BD - Bangladesh 380
CA - Canada 264
IR - Iran 242
ID - Indonesia 221
TR - Turchia 219
NL - Olanda 214
AR - Argentina 209
IQ - Iraq 203
PK - Pakistan 203
KR - Corea 195
JP - Giappone 160
IE - Irlanda 151
ZA - Sudafrica 146
AU - Australia 142
TW - Taiwan 135
MX - Messico 119
BE - Belgio 116
MY - Malesia 115
SA - Arabia Saudita 110
EC - Ecuador 109
CI - Costa d'Avorio 102
CO - Colombia 96
PH - Filippine 87
PL - Polonia 79
AT - Austria 77
ES - Italia 76
MA - Marocco 75
EG - Egitto 69
UZ - Uzbekistan 66
ET - Etiopia 64
VE - Venezuela 62
TN - Tunisia 50
AE - Emirati Arabi Uniti 49
CH - Svizzera 48
NG - Nigeria 48
CL - Cile 46
KE - Kenya 44
IL - Israele 35
NO - Norvegia 34
DZ - Algeria 33
JM - Giamaica 32
TH - Thailandia 32
PY - Paraguay 30
RO - Romania 29
JO - Giordania 28
NP - Nepal 28
NZ - Nuova Zelanda 28
GH - Ghana 27
UY - Uruguay 27
CZ - Repubblica Ceca 25
PE - Perù 25
PT - Portogallo 25
AZ - Azerbaigian 24
CR - Costa Rica 23
LT - Lituania 19
RS - Serbia 19
BO - Bolivia 18
KZ - Kazakistan 17
OM - Oman 17
LB - Libano 15
DK - Danimarca 14
AL - Albania 13
BW - Botswana 12
GR - Grecia 12
PA - Panama 12
SN - Senegal 12
BG - Bulgaria 11
KG - Kirghizistan 11
NI - Nicaragua 11
BN - Brunei Darussalam 9
EU - Europa 9
GA - Gabon 9
GE - Georgia 9
HN - Honduras 9
HU - Ungheria 9
KW - Kuwait 9
LY - Libia 9
BH - Bahrain 8
DO - Repubblica Dominicana 8
PS - Palestinian Territory 8
SY - Repubblica araba siriana 8
TT - Trinidad e Tobago 8
LK - Sri Lanka 7
LU - Lussemburgo 7
XK - ???statistics.table.value.countryCode.XK??? 7
Totale 57.411
Città #
Fairfield 3.663
Ashburn 2.988
Woodbridge 2.453
Singapore 2.426
Houston 2.021
Chandler 1.934
Hong Kong 1.576
Seattle 1.543
San Jose 1.484
Jacksonville 1.365
Cambridge 1.285
Wilmington 1.178
Milan 1.083
Ann Arbor 916
Nyköping 730
Beijing 631
Dallas 585
Lawrence 445
Roxbury 435
New York 426
Lauterbourg 418
Nanjing 351
Los Angeles 331
Helsinki 325
Rome 310
Des Moines 307
Santa Clara 217
Boardman 212
Ho Chi Minh City 193
Bari 176
Munich 175
São Paulo 174
Brooklyn 153
San Diego 151
Hanoi 141
Council Bluffs 138
Dublin 136
Princeton 135
London 131
Paris 110
Buffalo 106
Figino 104
Abidjan 101
Dearborn 100
Jakarta 99
Chicago 97
Frankfurt am Main 96
Nanchang 96
Tokyo 94
Brussels 93
Shenyang 88
Dong Ket 86
Hebei 83
Inglewood 78
Jiaxing 77
Rio de Janeiro 75
Baghdad 74
Kuala Lumpur 74
The Dalles 74
Nuremberg 73
Dhaka 69
Falkenstein 69
Turin 68
San Francisco 64
Columbus 63
Orem 62
Moscow 61
Tianjin 61
Central 60
Tashkent 58
Atlanta 57
Chennai 57
Toronto 57
Manchester 56
Changsha 54
Taranto 53
Istanbul 52
Johannesburg 52
Phoenix 52
Tehran 51
Warsaw 51
Belo Horizonte 49
Montreal 48
Washington 48
Taipei 47
Quito 46
Brasília 45
Guangzhou 45
Norwalk 45
Pune 45
Redwood City 45
Stockholm 45
Lahore 44
Riyadh 44
Mumbai 43
Jeddah 42
Shanghai 42
Hyderabad 41
Melbourne 41
Mexico City 40
Totale 37.291
Nome #
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013 3.858
Cigarette smoking and the progression of multiple sclerosis 707
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: A systematic review 511
Prevalence of cognitive impairment and dementia in a population based study in Southern Italy: The Great Age study 358
Answer to "Social cognition assessment for mild neurocognitive disorders" 330
Ultrasound-Guided Injection of Botulinum Toxin Type A for Piriformis Muscle Syndrome: A Case Report and Review of the Literature 278
Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging 276
Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review 246
Age-related hearingimpairment and frailty in Alzheimer’s disease: interconnected associations and mechanisms 243
Age-specific ALS incidence: a dose–response meta-analysis 237
Plasma β-amyloid 1–42 reference values in cognitively normal subjects 233
A Preliminary Study on Augmenting Neuroimaging data using a Diffusion Model 229
Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review 226
Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 226
Qualitative analysis of the capacity to consent to treatment in patients with a chronic neurodegenerative disease. Alzheimer's Disease. 223
Comparative evaluation of two immunoassays for cerebrospinal fluid β-Amyloid 1–42 measurement 220
Social dysfunction in older age and relationships with cognition, depression, and apathy: The GreatAGE Study 219
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging 218
Age-related hearing impairment—a risk factor and frailty marker for dementia and AD 215
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry 202
Coffee consumption habits and the risk of mild cognitive impairment: The Italian longitudinal study on aging 202
The prevalence of peripheral and central hearing impairment and its relation to cognition in older adults 199
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 197
Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging 197
Epidemiology of age related hearing loss: A review 196
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention 196
A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy 195
Is Extracorporeal Shockwave Therapy Combined With Isokinetic Exercise More Effective Than Extracorporeal Shockwave Therapy Alone for Subacromial Impingement Syndrome? A Randomized Clinical Trial 192
COGNITIVE-HD study: Protocol of an observational study of neurocognitive functioning and association with clinical outcomes in adults with end-stage kidney disease treated with haemodialysis 192
Episodic memory and learning rates in amyotrophic lateral sclerosis without dementia 190
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia 189
Multicentre, cross-cultural, population-based, case-control study of physical activity as risk factor for amyotrophic lateral sclerosis 188
Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging. 186
Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype 185
Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review 184
Prefrontal activity and connectivity with basal ganglia during performance of complex cognitive tasks is associated with apathy in healthy subjects 183
Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study 182
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study 182
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis 179
Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort 177
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients 176
Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases 176
Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial 176
Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern Italy 175
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 174
Bioelectrical correlates of emotional changes induced by environmental sound and colour: from virtual reality to real life 174
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis 174
Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease 173
An update on the use of gamma (multi)sensory stimulation for Alzheimer’s disease treatment 172
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis 172
A Machine Learning Approach to Parkinson's Disease Blood Transcriptomics 170
The age-related central auditory processing disorder: Silent impairment of the cognitive ear 170
Epidemiology of neurodegenerative diseases 169
Classification of healthy subjects and Alzheimer's disease patients with dementia from cortical sources of resting state EEG rhythms: A study using artificial neural networks 168
BACE inhibitors in clinical development for the treatment of Alzheimer’s disease 168
Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline 167
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 165
Cognitive frailty: a potential target for secondary prevention of dementia 164
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis 164
Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder 164
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 164
Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres 162
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? 162
Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosis 161
Factors predicting survival in ALS: a multicenter Italian study 161
Variation in world wide incidence of amyotrophic lateral sclerosis: A meta-analysis 160
A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: A questionnaire-based retrospective study 160
Evaluation of endothelial function and cardiovascular risk in non-obese patients with slight degree of obstructive sleep apnea syndrome 159
The Role of Hearing Impairment in Cognitive Decline: Need for the Special Sense Assessment in Evaluating Cognition in Older Age 159
Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR 159
Tau aggregation inhibitors: The future of Alzheimer's pharmacotherapy? 158
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017 158
Bipolar disorder and frontotemporal dementia: An intriguing association 156
Retinal Vascular Density on Optical Coherence Tomography Angiography and Age-related Central and Peripheral Hearing Loss in a Southern Italian Older Population 156
Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 155
Unreported financial disclosures in a study of migraine and cardiovascular disease 154
Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease. 154
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 154
Accuracy of clinical diagnosis of Parkinson disease. A systematic review and meta-analysis 153
. Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging 151
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective? 151
Screening for aphasia in neurodegeneration for the diagnosis of patients with primary progressive aphasia: Clinical validity and psychometric properties 150
Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke 148
Amyloid-related imaging abnormalities associated with immunotherapy in Alzheimer's disease patients 148
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. 148
Late-onset depression is associated to age-related central auditory processing disorder in an older population in Southern Italy 148
Early pathological gambling in co-occurrence with semantic variant primary progressive aphasia: A case report 147
Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging 146
Multicentre, population-based, case-control study of particulates, combustion products and amyotrophic lateral sclerosis risk 146
Loss of Swallow Tail Sign on Susceptibility-Weighted Imaging in Dementia with Lewy Bodies 146
Agreement among neurologists on the clinical diagnosis of dystonia at different body sites 145
Response to Letter to the Editor: “Plasma β-amyloid1–42 reference values” 145
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 144
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 144
Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know? 143
Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis 143
Nutrition, frailty, and Alzheimer's disease. 142
The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset 141
Clinical features and genetic characterization of two dizygotic twins with C9orf72 expansion 141
Age-Related Central Auditory Processing Disorder, MCI, and Dementia in an Older Population of Southern Italy 141
Totale 22.520
Categoria #
all - tutte 220.065
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 220.065


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.928 148 177 21 133 158 340 77 156 243 211 434 830
2022/20234.752 722 468 304 427 563 548 96 574 803 38 133 76
2023/20244.501 348 629 357 335 425 1.095 484 440 88 44 51 205
2024/20258.576 250 224 905 474 255 822 704 685 363 451 1.160 2.283
2025/202617.364 2.368 544 1.194 1.540 1.522 1.037 2.004 625 2.256 1.551 703 2.020
2026/2027652 652 0 0 0 0 0 0 0 0 0 0 0
Totale 59.057